Combined mutation pattern analyses of epidermal growth factor receptor and K-ras genes for the diagnosis of primary versus metastatic lung adenocarcinomas

被引：1
|
作者：
Takamochi, K. [1 ]
Oh, S. [1 ]
Suzuki, K. [1 ]
机构：
[1] Juntendo Univ, Sch Med, Tokyo 113, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2010年 / 28卷 / 15期
关键词：
D O I：
10.1200/jco.2010.28.15_suppl.e21010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21010
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Differential diagnosis of primary versus metastatic pulmonary adenocarcinomas using gene mutation analyses - A case report
    Nakazato, Yoshimasa
    Tanaka, Ryota
    Seki, Erina
    Iijima, Misa
    Kojima, Masaru
    Yoshizumi, Masakazu
    Kato, Masahiko
    Kimura, Hirokazu
    Kozawa, Kunihisa
    Goya, Tomoyuki
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) : 931 - 934
  • [22] An effect of K-ras gene mutation on epidermal growth factor receptor signal transduction in PANC-1 pancreatic carcinoma cells
    Watanabe, M
    Nobuta, A
    Tanaka, J
    Asaka, M
    INTERNATIONAL JOURNAL OF CANCER, 1996, 67 (02) : 264 - 268
  • [23] The genetic status of the EGFR, K-ras, and EML4-ALK genes in multiple primary noninvasive lung adenocarcinomas
    Sugio, Kenji
    Seto, Takashi
    Ichinose, Yukito
    Taguchi, Kenichi
    Nosaki, Kaname
    Ohba, Taro
    Toyokawa, Gohshi
    Hirai, Fumihiko
    Yamaguchi, Masafumi
    Maruyama, Riichiroh
    Hamatake, Motoharu
    CLINICAL CANCER RESEARCH, 2012, 18 (03)
  • [24] Spontaneous regression in a primary adenocarcinoma of lung with epidermal growth factor receptor mutation
    Ahmad, Farhan
    Singh, Shalini
    Kumari, Niraj
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (06) : 1817 - 1819
  • [25] Assessment of epidermal growth factor receptor (EGFR) and K-ras mutation status in cytologic stained smears of non-small cell lung cancer (NSCLC) patients
    Lozano, M. D.
    Gurpide, A.
    Echeveste, J. I.
    Del Barrio, A.
    Perez-Gracia, J. L.
    Seijo, L. M.
    Zuluela, J.
    Lopez-Picazo, J. M.
    Gil-Bazo, I.
    Martin-Algarra, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] Response to First-Line Chemotherapy in Patients With Non-Small-Cell Lung Cancer According to Epidermal Growth Factor Receptor and K-RAS Mutation Status
    Dong, Xiaopeng
    Zhao, Xiaogang
    Hao, Yingtao
    Wei, Yucheng
    Yin, Qiuwei
    Du, Jiajun
    CLINICAL LUNG CANCER, 2013, 14 (06) : 680 - 687
  • [27] Role of epidermal growth factor receptor overexpression, K-ras point mutation and c-myc amplification in the carcinogenesis of non-small cell lung cancer
    Sekine, I
    Takami, S
    Guang, SG
    Yokose, T
    Kodama, T
    Nishiwaki, Y
    Kinoshita, M
    Matsumoto, H
    Ogura, T
    Nagai, K
    ONCOLOGY REPORTS, 1998, 5 (02) : 351 - 354
  • [28] Epidermal growth factor receptor gene mutation defines distinct subsets among small adenocarcinomas of the lung
    Haneda, H
    Sasaki, H
    Shimizu, S
    Endo, K
    Suzuki, E
    Yukiue, H
    Kobayashi, Y
    Yano, M
    Fujii, Y
    LUNG CANCER, 2006, 52 (01) : 47 - 52
  • [29] Association of epidermal growth factor receptor and K-Ras mutations with smoking history in non-small cell lung cancer patients
    Baykara, Onur
    Tansarikaya, Merve
    Demirkaya, Ahmet
    Kaynak, Kamil
    Tanju, Serhan
    Toker, Alper
    Buyru, Nur
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 5 (02) : 495 - 498
  • [30] Novel mutations and mutation pattern of epidermal growth factor receptor (EGFR) gene in Chinese patients with primary lung adenocarcinoma
    Mok, T.
    Lui, P.
    Lam, K. C.
    Yim, A.
    Wan, I.
    Lee, S.
    Hsin, M.
    Leung, L.
    To, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345